SCHEMBL7475844

SCHEMBL7475844

Cc1ccccc1-c1cc(Br)cc(-c2ccccc2C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
ALDH1A1 P00352 2/20 0.42
HTR7 P34969 3/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
MCL1 Q07820 1/20 0.41
TRPA1 O75762 1/20 0.40
CTSD P07339 1/20 0.40
BACE1 P56817 1/20 0.40
ACHE P22303 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
GRIA1 P42261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19897390 0.88 TSHR (0.50) TSHRNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL23422186 0.86 NPC1 (0.41) TSHRNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL30363280 0.86 NPC1 (0.41) TSHRNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL961660 0.83 HTR7 (0.51) TSHRNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL30919711 0.83 HTR7 (0.51) TSHRNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL31433487 0.81 TSHR (0.34) TSHRNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL21230086 0.79 HTR7 (0.47) TSHRNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL3361069 0.79 HTR7 (0.43) TSHRNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL1841291 0.79 TSHR (0.59) TSHRNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL31621546 0.78 MAOB (0.38) TSHRNPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100308313-A1 Organic Material Containing Oligophenylene Skeleton and Light-Emitting Device Using the Same NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY 2010-12-09 US disclosed
US-20100308313-A1 Organic Material Containing Oligophenylene Skeleton and Light-Emitting Device Using the Same NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY 2010-12-09 US disclosed
EP-2236485-A1 ORGANIC MATERIAL CONTAINING OLIGOPHENYLENE SKELETON AND LIGHT-EMITTING DEVICE USING THE SAME National University Corporation Nagoya University (JP) 2010-10-06 EP disclosed
EP-0952200-B1 Organic electroluminescent elements for stable blue electroluminescent devices EASTMAN KODAK CO (US) 2002-12-18 EP disclosed
EP-0952200-A2 Organic electroluminescent elements for stable blue electroluminescent devices EASTMAN KODAK COMPANY (US) 1999-10-27 EP disclosed
US-5972247-A FOR BLUE ELECTROLUMINESCENT DEVICES; FLAT PANEL DISPLAYS EASTMAN KODAK COMPANY (US) 1999-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100308313-A1 Organic Material Containing Oligophenylene Skeleton and Light-Emitting Device Using the Same BMP2, SOST, BMP4 TSHR 4853/4885NPC1 2973/4885RAB9A 1215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.